A novel approach to evaluate the pharmacodynamics of a selective dopamine D1/D5 receptor partial agonist PF-06412562 in patients with stable schizophrenia. Arce, E., Balice-Gordon, R., Duvvuri, S., Naylor, M., Xie, Z., Harel, B., Kozak, R., Gray, D., & DeMartinis, N.
2019. Journal of Psychopharmacology.
Read